Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1981-06-02
1984-10-23
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
424 9, 252645, A61K 4300, A61K 4900
Patent
active
044788150
ABSTRACT:
F(ab').sub.2 or Fab fragments of antibodies to: (a) human chorionic gonadotropin (hCG), hCG alpha subunit, hCG beta subunit, or an hCG-like material; or (b) other tumor specific or tumor associated molecules, to include carcinoembryonic antigen (CEA), alpha fetoprotein (AFP), human melanoma associated antigens, human sarcoma associated antigens or other antigens, are radiolabeled with technetium-99m (Tc-99m). When the F(ab').sub.2 or Fab fragments of antibody to such tumor associated antigens are injected intravenously into a patient, the radiolabeled composition accumulates at tumor sites. The accumulation of the cancer seeking radiopharmaceutical at tumor sites permits detection by external gamma scintigraphy. Thus, the composition is useful in the monitoring, localization and detection of cancer in the body.
In an alternative composition, a double antibody approach to tumor localization using radiolabeled F(ab').sub.2 or Fab fragments is utilized. In this approach, a tumor specific antibody in the form of IgG, F(ab').sub.2 or Fab is first administered to a patient intravenously. Following a sufficient period of time, a second antibody in the form of F(ab').sub.2 or Fab is administered. The second antibody is radiolabeled with Tc-99m and has the property that it is reactive with the first antibody. This double antibody method has the advantage over a single antibody approach in that smaller tumors can be localized and detected and that the total amount of radioactive trace localized at the cancer site is increased.
REFERENCES:
patent: 4311688 (1982-01-01), Burchiel et al.
patent: 4323546 (1982-04-01), Crockford et al.
patent: 4331647 (1982-05-01), Goldenberg
patent: 4348376 (1982-09-01), Goldenberg
Burchiel Scott W.
Crockford David R.
Rhodes Buck A.
Cook Paul J.
Nuc-Med, Inc.
Nucker Christine M.
University Patents Inc.
LandOfFree
Composition and method for detecting cancer with technetium labe does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and method for detecting cancer with technetium labe, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method for detecting cancer with technetium labe will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1598592